piperidines and Neurodevelopmental-Disorders

piperidines has been researched along with Neurodevelopmental-Disorders* in 2 studies

Other Studies

2 other study(ies) available for piperidines and Neurodevelopmental-Disorders

ArticleYear
Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 04-02, Volume: 116, Issue:14

    Maternal infection during pregnancy increases risk of neurodevelopmental disorders such as schizophrenia and autism spectrum disorder (ASD) in offspring. In rodents, maternal immune activation (MIA) yields offspring with schizophrenia- and ASD-like behavioral abnormalities. Soluble epoxide hydrolase (sEH) plays a key role in inflammation associated with neurodevelopmental disorders. Here we found higher levels of sEH in the prefrontal cortex (PFC) of juvenile offspring after MIA. Oxylipin analysis showed decreased levels of epoxy fatty acids in the PFC of juvenile offspring after MIA, supporting increased activity of sEH in the PFC of juvenile offspring. Furthermore, expression of sEH (or

    Topics: Animals; Epoxide Hydrolases; Female; Gene Expression Regulation, Enzymologic; Maternal Exposure; Mice; Neurodevelopmental Disorders; Phenylurea Compounds; Piperidines; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Schizophrenia

2019
Potentiation of excitatory synaptic transmission ameliorates aggression in mice with Stxbp1 haploinsufficiency.
    Human molecular genetics, 2017, 12-15, Volume: 26, Issue:24

    Genetic studies point to a major role of de novo mutations in neurodevelopmental disorders of intellectual disability, autism spectrum disorders, and epileptic encephalopathy. The STXBP1 gene encodes the syntaxin-binding protein 1 (Munc18-1) that critically controls synaptic vesicle exocytosis and synaptic transmission. This gene harbors a high frequency of de novo mutations, which may play roles in these neurodevelopmental disorders. However, the system and behavioral-level pathophysiological changes caused by these genetic defects remain poorly understood. Constitutional (Stxbp1+/-), dorsal-telencephalic excitatory (Stxbp1fl/+/Emx), or global inhibitory neuron-specific (Stxbp1fl/+/Vgat) mice were subjected to a behavioral test battery examining locomotor activity, anxiety, fear learning, and social interactions including aggression. Furthermore, measurements of local field potentials in multiple regions of the brain were performed. Stxbp1+/- male mice exhibited enhanced aggressiveness and impaired fear learning associated with elevated gamma activity in several regions of the brain including the prefrontal cortex. Stxbp1fl/+/Emx mice showed fear-learning deficits, but neither Stxbp1fl/+/Emx nor Stxbp1fl/+/Vgat mice showed increased aggressiveness. Pharmacological potentiation of the excitatory transmission at active synapses via the systemic administration of ampakine CX516, which enhances the excitatory postsynaptic function, ameliorated the aggressive phenotype of Stxbp1+/- mice. These findings suggest that synaptic impairments of the dorsal telencephalic and subcortical excitatory neurons cause learning deficits and enhanced aggression in Stxbp1+/- mice, respectively. Additionally, normalizing the excitatory synaptic transmission is a potential therapeutic option for managing aggressiveness in patients with STXBP1 mutations.

    Topics: Aggression; Animals; Brain; Dioxoles; Excitatory Postsynaptic Potentials; Haploinsufficiency; Intellectual Disability; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Munc18 Proteins; Neurodevelopmental Disorders; Neurons; Piperidines; Synapses; Synaptic Transmission

2017